Search for Clinical Trial Results
Neurofibromatoses - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas Condition:
|
Recruiting |
Study Name: Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma Condition: Neurofibromatosis Type 1 Date: 2015-10-20 Interventions:
|
Recruiting |
Study Name: Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients Condition: Neurofibromatosis Type 1 Date: 2010-10-08 |
Recruiting |
Study Name: Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1 Condition: Neurofibromatosis Type 1 Date: 2016-05-25 Interventions:
|
Completed |
Study Name: Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Condition: Neurofibromatosis Date: 2012-08-22 Interventions: Drug: Gleevec Gleevec® will be dosed orally 440 mg/m^2/day (max 800 mg/day) for pediatric subjects |